APA-viite

Jebali, M., Elaidi, R., Brizard, M., Fouque, J., Takouchop, C., Sabatier, B., . . . Medioni, J. (2017). Biological toxicities as surrogate markers of efficacy in patients treated with mTOR inhibitors for metastatic renal cell carcinoma. BMC Cancer.

Chicago-tyylinen lähdeviittaus

Jebali, M., R. Elaidi, M. Brizard, J. Fouque, C. Takouchop, B. Sabatier, S. Oudard, ja J. Medioni. "Biological Toxicities As Surrogate Markers of Efficacy in Patients Treated With MTOR Inhibitors for Metastatic Renal Cell Carcinoma." BMC Cancer 2017.

MLA-viite

Jebali, M., et al. "Biological Toxicities As Surrogate Markers of Efficacy in Patients Treated With MTOR Inhibitors for Metastatic Renal Cell Carcinoma." BMC Cancer 2017.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.